Mark Levin, MD
Vascular Surgery · Reno, NVNPI 1730492414
Payments from drug & device makers
What this record shows
The money is spread across several categories — other (47.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Angiodynamics, Inc. accounts for 60.4% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2023 at $8,839 and has fallen 98.0% since, to $176 in 2025.
Across 110 payments — averaging $122.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$8K
- W. L. Gore & Associates, Inc.$2K
- Silk Road Medical, Inc.$611
- Boston Scientific$601
- Endologix LLC$434
- Cook Medical LLC$404
- plus $2K from 22 others
What the payments were for
- Travel & lodging$2,30517%
- Food & beverage$4,76235%
- Other$6,41748%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 8 | $8,144 |
| W. L. Gore & Associates, Inc. | 15 | $1,671 |
| Silk Road Medical, Inc. | 9 | $611 |
| Boston Scientific | 12 | $601 |
| Endologix LLC | 2 | $434 |
| Cook Medical LLC | 8 | $404 |
| Medtronic(2 entities) | 8 | $371 |
| Atricure, Inc. | 7 | $141 |
| Cardiovascular Systems Inc. | 6 | $138 |
| Amniox Medical, Inc. | 1 | $133 |
| Edwards Lifesciences | 3 | $87 |
| Inari Medical, Inc. | 1 | $78 |
| Lemaitre Vascular, Inc. | 3 | $70 |
| Cardiva Medical, Inc. | 2 | $69 |
| Bard Peripheral Vascular, Inc. | 4 | $60 |
| Terumo Medical Corporation | 3 | $57 |
| Shockwave Medical, Inc | 1 | $52 |
| Johnson & Johnson | 3 | $52 |
| Actelion Pharmaceuticals US, Inc. | 2 | $50 |
| Abbott | 3 | $49 |
| Penumbra, Inc. | 1 | $38 |
| Organogenesis Inc. | 1 | $33 |
| Alnylam Pharmaceuticals Inc. | 2 | $33 |
| Elutia, Inc. | 1 | $26 |
| AstraZeneca | 1 | $24 |
| Scpharmaceuticals Inc. | 1 | $23 |
| Mimedx Group, Inc. | 1 | $19 |
| Merck | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auryon Laser System 100-120 Vac$6,417
- GORE TAG Thoracic Endoprosthesis$1,180
- ENROUTE Transcarotid Neuroprotection System$479
- Alto Abdominal Stent Graft System$434
- ENROUTE Transcarotid Stent$304
- ENHANCE Transcarotid Peripheral Access Kit$295
- ENROUTE Transcarotid Stent System$175
- ENROUTE 0.014 Guidewire$175
- NEOX$133
- CLARIX$133
- Zenith Alpha$125
- ENROUTE .014 Guidewire$120
- GENERAL VASCULAR INTERVENTION$111
How this compares
$13,484 in reported general payments places this provider in the 60th percentile of 28 vascular surgery providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 11 | $9,525 |
| ClopidogrelClopidogrel Bisulfate | 86 | $1,013 |
| Rosuvastatin Calcium | 19 | $678 |
| Atorvastatin Calcium | 65 | $524 |
| Cilostazol | 14 | $163 |
| Oxycodone Hcl | 12 | $62 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $52 | $9,52511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 28 vascular surgery providers in Nevada.
Other vascular surgery in Reno
- Ashanga YatawattaReno$78K
- Thelinh NguyenReno$16K
- Janet AlbrightReno$14K
- David WarnerReno$4K
- Jessica WilliamsReno$2K
- Sherwood DixonReno$500
- George SieffertReno$112
- George PliagasLas Vegas$211K
- Sai KottapalliLas Vegas$53K
- Eddy LuhLas Vegas$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.